Market Tracker

03/24 5:16pm ET

Meridian Bioscience Inc (NASDAQ:VIVO)

13.10
Delayed Data
As of Mar 24
 +0.15 / +1.16%
Today’s Change
10.75
Today|||52-Week Range
21.49
-25.99%
Year-to-Date
MedTech Industry Outlook - March 2017
Mar 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close12.95
Today’s open13.00
Day’s range12.95 - 13.20
Volume182,663
Average volume (3 months)408,844
Market cap$552.8M
Dividend yield3.82%
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-10.59%
Earnings growth (this year)-17.71%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.64%
P/E ratio18.7
Price/Sales4.17
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
ALRPRBAlere Inc+7.50+2.33%
--Quidel Corp+0.40+2.07%
LNTHLantheus Holdings In...0.000.00%
CLDXCelldex Therapeutics...+0.06+1.83%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.19
Annual revenue (last year)$196.1M
Annual profit (last year)$32.2M
Net profit margin16.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John A. Kraeutler
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts